Advanced SearchNewsfeedFollowed Companies

Exact Sciences's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Exact Sciences, focused on the early detection and prevention of colorectal cancer.

Exact Sciences is a Public company. E... Read more

Based on data from Exact Sciences's latest SEC filings

Annual Revenue

Based on data from Exact Sciences's latest SEC filings

Employees

Kevin T. Conroy's photo - Chairman & CEO of Exact Sciences

Chairman & CEO

Kevin T. Conroy

CEO Approval Rating

90/100

OVERVIEW

Founded:

1995

Headquarters:

MadisonWisconsin

Status:

PublicNASDAQEXAS

Industry Sector:

Health Care Services

SIC Code:

8000NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Cernostics a competitor of Exact Sciences?

I don't know

Trending News for Exact Sciences and Exact Sciences's Competitors

February 26, 2020

centralcharts

Exact Sciences to participate in March investor conferences

Exact Sciences to participate in March investor conferences PR Newswire MADISON, Wis., Feb. 26, 2020 ... See more »

February 25, 2020

MarketScreener

Invitae : to Present at the Cowen and Company's 40th Annual Health Care Conference

(marketscreener.com) SAN FRANCISCO, Feb. 25, 2020 /PRNewswire/ -- Invitae Corporation , a leading med... See more »

Today 3:15 AM

Global Legal Chronicle

Decisio Health's $12 Million Series B Financing

Shearman & Sterling advised Decisio Health, Inc. on the deal. Decisio Health, Inc. raised $12 million... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Polymedco is the top competitor of Exact Sciences. Polymedco is headquartered in Cortlandt Manor, New York, and was founded in 1980. Polymedco competes in the Health Care Equipment field. Polymedco generates 3.83% the revenue of Exact Sciences.

Genomic Expression is perceived as one of Exact Sciences's biggest rivals. Genomic Expression was founded in New York, New York} in 2009. Like Exact Sciences, Genomic Expression also operates in the Health Care Services industry. Compared to Exact Sciences, Genomic Expression generates $868.7M less revenue.

Hemosure is seen as one of Exact Sciences's top competitors. Hemosure is a Private company that was founded in Irwindale, California in 2003. Hemosure operates in the industry. Hemosure has 1,881 fewer employees vs. Exact Sciences.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Kevin T. Conroy

Chairman & CEO

- -
1,977
$64.2M
$876.3M
1

Drew Cervasio

President

70/100
182
- -
$33.6M
2

Gitte Pedersen

Co-Founder & CEO

90/100
14
$4.4M
$7.6M
3

CEO

- -
96
- -
$14.9M
4

CEO

- -
80
$106.9M
$6.3M
5

Mike Hoerres

CEO

84/100
10
$16.6M
$5M
6

Thomas J. Kuehn

Chairman & CEO

71/100
33
- -
$4.4M
7

Francis deSouza

President & CEO

76/100
7,300
$96M
$604M
8

Cindy Perettie

CEO

80/100
535
$165.5M
$541.1M
9

Bryan Riggsbee

Interim-CEO

83/100
2,600
$249.4K
$813.4M
10

John L. Bishop

Chairman & CEO

68/100
1,700
$32.6M
$596.3M
The top 10 competitors in Exact Sciences' competitive set are Polymedco, Genomic Expression, Hemosure, Exosome Diagnostics, Cernostics, Metabiomics, Illumina, Foundation Medicine, Myriad Genetics and Cepheid. Together they have raised over 422.3M between their estimated 13.1K employees. Exact Sciences has 1,977 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 1,320.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$876.3M

Exact Sciences's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 318.4M. Over the last four quarters, Exact Sciences's revenue has grown by 82.4%. Specifically, in Q4 2019's revenue was $295.6M; in Q3 2019, it was $218.8M; in Q2 2019, it was $199.9M; in Q1 2019, Exact Sciences's revenue was $162M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Genomic Health Inc

Jul 2019

Source »
$2.8B
Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.
Biomatrica, Inc.

Oct 2018

Source »
undisclosed
Biomatrica is a biotechnology company that develops chemicals for ambient temperature preservation of biological materials.

These are all the companies that Exact Sciences has acquired. Exact Sciences has acquired 2 companies and its latest acquisition was Genomic Health Inc in Jul 2019. Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.

Exact Sciences Funding History

Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jan 2001 for a total of $56.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jan 2001
$56M

Equity
Jun 2009
$8.2M
-

Total Funding: $64.2M

Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jan 2001 for a total of $56.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Thrive develops a liquid biopsy-based testing platform that allows physicians to detect cancer disease.
$110M
May 29, 2019
Series A
-

These are all the companies that Exact Sciences has invested in. Exact Sciences has invested 2 companies and its latest investment was Genomic Health Inc in Jul 2019. Genomic Health is a biotechnology company that provides genomic-based diagnostic test services to the treatment of early-stage cancer.

Exact Sciences News

February 11, 2020The Business Journals: Greensboro/Winston-Salem/High Point

Exact Sciences beats shares, revenue projections in 4Q earnings report

Madison-based Exact Sciences Corp. beat Wall Street analysts' revenue and earnings per share projecti... See more »
February 6, 2020DirectorsTalk Interviews

Exact Sciences Corporation - Consenus Indicates Potential 26.9% Upside

Exact Sciences Corporation with ticker code (EXAS) have now 14 analysts covering the stock with the c... See more »
February 6, 2020The Markets Daily

Brokerages Anticipate EXACT Sciences Co. (NASDAQ:EXAS) to Announce -$0.37 EPS

Wall Street analysts forecast that EXACT Sciences Co. (NASDAQ:EXAS) will post ($0.37) earnings per sh... See more »
January 27, 2020BioSpace

Exact Sciences schedules fourth-quarter, full-year 2019 earnings call

Exact Sciences Corp. announced that the company plans to release its fourth-quarter and full-year 201... See more »
January 23, 2020The Business Journals: Greensboro/Winston-Salem/High Point

Exact Sciences' stock jumps after analysts question competitor's product

Thanks to a competitor disclosing data showing its screening test isn't as efficient at detecting ear... See more »
January 22, 2020Seeking Alpha

Exact Sciences up 10% on diminished competitive concerns

See more »
January 13, 2020The Business Journals: Greensboro/Winston-Salem/High Point

Exact Sciences anticipates 2019 revenue over $876M, more than 1.6M completed Cologuard tests

With the $2.8 billion acquisition deal of California's Genomic Health officially completed, Madison-b... See more »

Exact Sciences Blogs

May 15, 2015EXACT SCIENCES BLOG

Exact Sciences' Stool DNA Screening Technology Featured in Posters at Digestive Disease Week 2015

See more »
February 2, 2015EXACT SCIENCES BLOG

Exact Sciences' Growth Leads Wisconsin State Journal

See more »
January 13, 2015EXACT SCIENCES BLOG

Cologuard® Wins Everyday Health Award For Innovation

See more »
December 9, 2014EXACT SCIENCES BLOG

Exact Sciences Named A Best Company To Work For By In Business Madison

See more »
November 26, 2014EXACT SCIENCES BLOG

Giving Thanks to Madison this Season

See more »
September 4, 2014EXACT SCIENCES BLOG

Cologuard® in the News: Week Three

See more »
August 28, 2014EXACT SCIENCES BLOG

Cologuard® in the News: Week Two

See more »

Exact Sciences Press Releases

October 29, 2019PR Newswire

Exact Sciences Presents New Stool-Based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

MADISON, Wis., Oct. 29, 2019 /PRNewswire/ -- (NASDAQ: EXAS) - Promising research from Exact Sciences ... See more »
September 19, 2019centralcharts

Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work® and FORTUNE

Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work® and FORTUNE Op... See more »
September 10, 2019StreetInsider

Cologuard® Helps More People Get Screened In A Cost-Effective Way

See more »
March 1, 2019centralcharts

Exact Sciences to participate in March investor conferences

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention... See more »
December 20, 2018centralcharts

Exact Sciences to participate in J.P. Morgan Healthcare Conference

Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire MADISON, Wis., Dec. 2... See more »
November 9, 2018PR Newswire

Exact Sciences to participate in two November investor conferences

MADISON, Wis., Nov. 9, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that ... See more »
October 30, 2018PR Newswire

Cologuard® revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter

MADISON, Wis., Oct. 30, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that... See more »

Exact Sciences Videos

August 27, 2018Exact Sciences Youtube Channel

"Fight Colorectal Cancer Ambassador John MacLeod: I'm still here." on YOUTUBE

See more »

Social Statistics

Headquarters

441 Charmany Drive

Madison, Wisconsin53719

608-284-5700

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Exact Sciences, focused on the early detection and prevention of colorectal cancer. Exact Sciences was founded in 1995. Exact Sciences' headquarters is located in Madison, Wisconsin, USA 53719. It has raised 64.2M in 2 rounds. The latest round was in ...

CEO

Exact Sciences's Chairman & CEO, Kevin T. Conroy, currently has an approval rating of 90%. Exact Sciences's primary competitors are Polymedco, Genomic Expression & Hemosure.

Website

exactsciences.com

Frequently Asked Questions about Exact Sciences

  1. When was Exact Sciences founded?

    Exact Sciences was founded in 1995

  2. Who is Exact Sciences's CEO?

    Exact Sciences's CEO is Kevin T. Conroy

  3. How much revenue does Exact Sciences generate?

    Exact Sciences generates $876.3M in revenue

  4. How much funding does Exact Sciences have?

    Exact Sciences has historically raised $64.2M in funding

  5. Where is Exact Sciences's headquarters?

    Exact Sciences's headquarters is in Madison Wisconsin, USA

  1. How many employees does Exact Sciences have?

    Exact Sciences has 1,977 employees

  2. What sector does Exact Sciences operate in?

    Exact Sciences is in Health Care Services

  3. Who are Exact Sciences's competitors?

    Exact Sciences's top competitors are Polymedco, Genomic Expression, Hemosure

  4. Who has Exact Sciences invested in?

    Exact Sciences's has invested in companies such as Thrive Earlier Detection
Stay up-to-date with the latest news on Exact Sciences